Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

7 Software Stocks to Buy Now

This week, seven software stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

6 Restaurant and Resort Stocks to Buy Now

The grades of six restaurant and resort stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

5 Fashion and Apparel Stocks to Buy Now

This week, five fashion and apparel stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Royal Dutch Shell (RDS.A) Is Just Killing It

Shell's buyout of BG was only the beginning. The company's latest win will have shareholders singing for a long time.

FB to Challenge EBAY With Auction Feature

There have been reports of an EBAY-style sales platform coming to FB. If successful, the new feature could be devastating to eBay.

JCP Stock Is a Better Buy Than Its Earnings Response Suggests

For patient investors who can see more than a few months down the road, JCP stock actually offers more reward than risk.

5 Stocks With Superb Earnings Surprises — ABMD UBA WRI RDCM BRE

This week, these five stocks have the best ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.

Healthcare Stocks Showdown: UNH vs. ANTM

When choosing your favorite healthcare stocks, you must decide -- are you a people person or a systems person? We'll compare UNH stock and ANTM stock.

4 Commercial Services Stocks to Buy Now

The grades of four commercial services stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

5 Biotechnology Stocks to Buy Now

The grades of five biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

SONC: Drive Away With Profits on This Small-Cap Stock

There are three important factors working in the favor of Sonic Corporation. Although overlooked by many, SONC stock is set to drive higher.

6 Insurance Stocks to Buy Now

This week, six insurance stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

Medivation Stock – Jump Ahead of the Future With MDVN

Medivation (MDVN) is the latest iteration of the new breed of biotech stocks that are changing the medical landscape.

ARM Holdings: ARMH Gets Ready for Liftoff

ARM Holdings has a great business model in licensing out its ideas. ARMH stock should be a strong growth stock and could reach $75 per share.

3 Blue Chips You Should Love for Their Short Squeeze Potential

These three blue chips are actually reaping multiple benefits from short interest -- but naturally, what we love most are their chances for a short squeeze higher.

5 Semiconductor Stocks to Buy Now

This week, five semiconductor stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

10 Best “Strong Buy” Stocks — JBLU IPXL ELLI and more

This week, these ten stocks, all currently earning A's ("strong buy") on Portfolio Grader, have the best year-to-date performance.

5 Stocks With Great Earnings Momentum — KNSY FTEK QLYS EVAC CEB

This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

21 Upgraded Blue-Chip Stocks to Buy

After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise rankings for many of my big blue-chip stocks.